We are thrilled to announce that inne, a pioneering biotech startup based in Berlin, has successfully raised €10 million in its latest funding round, aimed at enhancing women's reproductive health through innovative technology. With a mission to empower women to track their fertility more accurately and conveniently, inne is reimagining how females interact with their reproductive systems. Our cutting-edge biochemistry approach includes a flexible, at-home saliva test that provides real-time insights into hormone levels, enabling users to predict and confirm ovulation with unparalleled precision. Coupled with our user-friendly mobile app, women can interpret these hormone fluctuations to make informed decisions about their fertility and overall health.
The funding will be instrumental in accelerating our research and development efforts, expanding our product line, and enhancing the educational resources available through our app. We believe that understanding one’s body should be accessible to all women, and with this new investment, we are well-positioned to reach a broader audience while continuing to innovate in the field of reproductive health. As we push the boundaries of science, technology, and design, we remain steadfast in our commitment to transforming the narrative around female health into one that celebrates both its beauty and logic. A heartfelt thank you to our investors for believing in our vision—together, we are set to make significant strides in empowering women to take control of their reproductive health.
